Pfizer And BioNTech Announce Phase 3 Trial Data Showing High Efficacy Of A Booster Dose Of Their COVID-19 Vaccine Read more
Registration is now open for the Pre-filled Syringes and Injectable devices Conference 2022 Read more
Biotage acquires ATDBio and strengthens its position in DNA and RNA Oligonucleotide synthesis and purification Read more
BeiGene and Nanolek Announce Approval in Russia for BRUKINSA® (Zanubrutinib) for Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma Read more
Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S. Read more
Moleculin Receives Authorization from the Medicines and Healthcare Products Regulatory Agency (MHRA) to Commence Phase 1a Clinical Trial of WP1122 for the Treatment of COVID-19 Read more
Conference Chair Di Morris, AstraZeneca invites Microbiologists to join SMi’s 10th Annual Pharmaceutical Microbiology Conference Read more
FSD Pharma Signs Agreement with Covar Pharmaceuticals to Support the Development of Lucid-PSYCH Read more